Royal Sense

What does Royal do?

Royal Sense Ltd is a micro-cap company in the healthcare services industry, incorporated on April 6, 2023, and previously operated by Rishabh Arora. It has a market cap of Rs 122 Cr, a P/E ratio of 19.00, and a return on equity of 34.74%.

Overview:<BR>Royal Sense Ltd operates in the healthcare services industry and is categorized as a micro-cap company.<BR><BR>History:<BR>Royal Sense Ltd was incorporated as a Public Limited Company on April 06, 2023. Prior to this incorporation, the business was operated by Promoter Rishabh Arora under various sole proprietorships.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: Rs 122 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 19.00<BR>Industry P/E: N/A<BR>Dividend Yield: 0.00%<BR>Debt-Equity: -0.39<BR>Return on Equity: 34.74%<BR>Price-to-Book: 6.73<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Has Royal declared dividend?

No Dividend History Available

What is the technical trend for Royal?

As of June 5, 2025, Royal's technical trend is neutral with mixed signals, showing a shift from mildly bearish to sideways, supported by a bullish weekly MACD and mildly bullish weekly KST, while daily moving averages indicate short-term weakness and the RSI shows no clear direction.

As of 5 June 2025, the technical trend for Royal has changed from mildly bearish to sideways. The weekly MACD is bullish, indicating some positive momentum, while the daily moving averages remain mildly bearish, suggesting short-term weakness. The weekly KST is mildly bullish, which adds some support to the overall stance. However, the RSI shows no signal on both weekly and monthly time frames, indicating a lack of clear direction. Overall, the current technical stance is neutral with mixed signals, reflecting indecision in the market.

Who are the peers of the Royal Sense?

Royal Sense's peers include Hemant Surgical, Bilcare, Take Solutions, Choksi Laborator, Jeevan Scienti., Centenial Surgic, Aspira Pathlab, N G Industries, and Aakaar Medical. In terms of management risk, growth, and capital structure, Royal Sense shows good performance, with a 1-year return of 44.00%, significantly higher than Take Solutions' -52.91%.

Peers: The peers of Royal Sense are Hemant Surgical, Bilcare, Take Solutions, Choksi Laborator, Jeevan Scienti., Centenial Surgic, Aspira Pathlab, N G Industries, Aakaar Medical.<BR><BR>Quality Snapshot: Excellent management risk is observed at Hemant Surgical and Aakaar Medical, while Good management risk is found at Royal Sense. Average management risk is present at Jeevan Scienti. and N G Industries, while Below Average management risk is noted at Bilcare, Take Solutions, Choksi Laborator, Centenial Surgic, Aspira Pathlab. In terms of growth, Excellent growth is seen at Royal Sense and Aakaar Medical, while Average growth is noted at Choksi Laborator, and Below Average growth is found at Hemant Surgical, Bilcare, Take Solutions, Jeevan Scienti., Centenial Surgic, Aspira Pathlab, N G Industries. Lastly, Excellent capital structure is observed at Hemant Surgical and Royal Sense, while Good capital structure is noted at Centenial Surgic and N G Industries, and Below Average capital structure is present at Bilcare, Take Solutions, Choksi Laborator, Jeevan Scienti., Aspira Pathlab, Aakaar Medical.<BR><BR>Return Snapshot: Choksi Laborator has the highest 1-year return at 242.39%, while Take Solutions has the lowest at -52.91%. Royal Sense's 1-year return of 44.00% is significantly higher than that of Take Solutions. Additionally, peers with negative six-month returns include Take Solutions, Aspira Pathlab, and N G Industries.

Who are the top shareholders of the Royal Sense?

The top shareholder of Royal Sense is Rishabh Arora, holding 61.5% of the shares, with no pledged promoter holdings. Individual investors own 24.17%, while the highest public shareholder is Manish Kumar (HUF) at 1.87%.

The top shareholders of Royal Sense are primarily the promoters, with Rishabh Arora holding the largest stake at 61.5%. There are no pledged promoter holdings, and mutual funds and foreign institutional investors do not hold any shares in the company. The highest public shareholder is Manish Kumar (HUF), who holds 1.87%. Individual investors collectively own 24.17% of the shares.

How big is Royal Sense?

As of 23rd July, Royal Sense Ltd has a market capitalization of 112.00 Cr, classifying it as a Micro Cap company. Recent quarterly performance data is unavailable, with the latest annual balance sheet showing Shareholder's Funds at 18.22 Cr and Total Assets at 20.77 Cr as of March 2024.

As of 23rd July, Royal Sense Ltd has a market capitalization of 112.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent quarterly performance data is not available, so there are no figures for Net Sales or Net Profit for the latest four quarters.<BR><BR>The latest annual period for the balance sheet is March 2024, with Shareholder's Funds reported at 18.22 Cr and Total Assets at 20.77 Cr.

When is the next results date for Royal Sense?

The next results date for Royal Sense is 13 November 2025.

The next results date for Royal Sense is scheduled for 13 November 2025.

How has been the historical performance of Royal Sense?

Royal Sense experienced significant growth from March 2024 to March 2025, with net sales increasing to 61.73 Cr from 17.80 Cr, and profit after tax rising to 6.33 Cr from 1.59 Cr. Key metrics such as operating profit and cash flow also improved, reflecting strong overall financial performance.

Answer:<BR>The historical performance of Royal Sense shows significant growth from March 2024 to March 2025.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Royal Sense reported net sales of 61.73 Cr, a substantial increase from 17.80 Cr in the previous year. Total operating income mirrored this growth, reaching 61.73 Cr compared to 17.80 Cr in March 2024. The company's total expenditure also rose to 52.85 Cr from 15.53 Cr, primarily driven by an increase in the purchase of finished goods, which rose to 51.18 Cr from 18.78 Cr. Operating profit (PBDIT) increased to 8.96 Cr from 2.30 Cr, resulting in an operating profit margin of 14.39%, up from 12.75%. Profit before tax surged to 8.73 Cr from 2.20 Cr, leading to a profit after tax of 6.33 Cr, compared to 1.59 Cr the previous year, reflecting a PAT margin of 10.25%, up from 8.93%. The company's total assets grew to 35.56 Cr from 20.77 Cr, while total liabilities increased to 35.56 Cr from 20.77 Cr, with total debt rising to 3.26 Cr from 1.60 Cr. Cash flow from operating activities improved to 1.00 Cr from -3.00 Cr, and the closing cash and cash equivalents rose to 11.00 Cr from 8.00 Cr, indicating a positive cash position. Overall, Royal Sense demonstrated strong financial performance and growth across key metrics.

Is Royal Sense overvalued or undervalued?

As of November 17, 2025, Royal Sense is considered overvalued with a valuation grade of very expensive, reflected in its PE ratio of 19.61 and EV to EBIT ratio of 14.67, despite a 1-year stock return of 10.74% that slightly outperformed the Sensex.

As of 17 November 2025, the valuation grade for Royal Sense has moved from very attractive to very expensive, indicating a significant shift in its market perception. The company is currently considered overvalued. Key ratios include a PE ratio of 19.61, an EV to EBIT ratio of 14.67, and a ROCE of 21.47%. <BR><BR>In comparison to its peers, Royal Sense's PE ratio is notably lower than Elitecon International's staggering 294.38, yet higher than PTC India's attractive 7.56. Additionally, Royal Sense's EV to EBITDA ratio of 14.64 suggests it is trading at a premium relative to the industry. Despite a 1-year stock return of 10.74%, which slightly outperformed the Sensex's 9.50%, the overall valuation metrics indicate that Royal Sense is currently overvalued in the healthcare services sector.

Why is Royal Sense Ltd falling/rising?

As of 04-Mar, Royal Sense Ltd's stock price is at 165.00, down 1.79% and has declined 4.07% over the past two days. The stock is underperforming against the Sensex and has seen a 29.73% drop over the past year, coupled with reduced investor interest.

As of 04-Mar, Royal Sense Ltd's stock price is currently at 165.00, reflecting a decrease of 3.0 points or 1.79%. The stock has been experiencing a consecutive decline over the past two days, with a total drop of 4.07% during this period. This downward trend is further supported by the fact that the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a sustained weakness in its price performance.<BR><BR>In addition to the stock's immediate performance, the broader market context shows that Royal Sense Ltd has underperformed compared to the Sensex over various time frames, including a significant decline of 29.73% over the past year, while the Sensex has gained 8.39%. Furthermore, there has been a notable decrease in investor participation, with the delivery volume dropping by 25% compared to the 5-day average, suggesting reduced interest in trading the stock.<BR><BR>Overall, these factors contribute to the ongoing decline in Royal Sense Ltd's stock price, reflecting both internal performance issues and external market conditions.

Which are the latest news on Royal Sense?